2-Chloro-6-(dimethylamino)nicotinic acid

Catalog No.: 
ACZHEM240
CAS No.: 
959577-31-2
Molecular Formula: 
C8H9ClN2O2
Molecular Weight: 
200.63
2-Chloro-6-(dimethylamino)nicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$237.00InquiryInquiry
250mg98%$446.00InquiryInquiry
1g98%$1748.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-6-(dimethylamino)nicotinic acid
IUPAC Name2-chloro-6-(dimethylamino)nicotinic acid
MDL No.MFCD01861973
Molecular FormulaC8H9ClN2O2
Molecular Weight200.63
SMILESO=C(O)C1=C(Cl)N=C(N(C)C)C=C1
InChI KeyKCELKMBUYRXARZ-UHFFFAOYSA-N
Synonym2-Chloro-6-(dimethylamino)nicotinic acid;2-Chloro-6-(dimethylamino)pyridine-3-carboxylic acid, 3-Carboxy-2-chloro-6-(dimethylamino)pyridine;3-Pyridinecarboxylic acid, 2-chloro-6-(dimethylamino)-
CAS No.959577-31-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZHEM240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBJSC259 route compound structure diagram
    ACBJSC25938496-18-3In Stock
  4. Then
  5. ACZHEM240 route product structure diagram
    ACZHEM240959577-31-2
Inquiry

2. ACZHEM240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZHEM240 route product structure diagram
    ACZHEM240959577-31-2
Inquiry

3. ACZHEM240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZHEM240 route product structure diagram
    ACZHEM240959577-31-2
Inquiry

Comments (0)